Prognostic value of serum soluble IL2 receptor (sIL2R) level in patients with diffuse large B cell lymphoma (DLBCL), treated with CHOP or R-CHOP based therapy

被引：0
|
作者：
Oki, Yasuhiro [1 ]
Matsuo, Keitaro
Kato, Harumi [1 ]
Yamamoto, Kazuhito [1 ]
Kagami, Yoshitoyo [1 ]
Morishima, Yasuo [1 ]
机构：
[1] Aichi Canc Ctr, Dept Hematol & Cell Therapy, Nagoya, Aichi, Japan
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1569
引用
收藏
页码：469A / 469A
页数：1
相关论文
共 50 条
  • [1] Serum soluble interleukin-2 receptor (sIL-2R) level is associated with the outcome of patients with diffuse large B cell lymphoma treated with R-CHOP regimens
    Naoe Goto
    Hisashi Tsurumi
    Hideko Goto
    Yoriko Ino Shimomura
    Senji Kasahara
    Takeshi Hara
    Ichiro Yasuda
    Masahito Shimizu
    Nobuo Murakami
    Takeshi Yoshikawa
    Kenji Fukuno
    Takeshi Takahashi
    Yusuke Kito
    Tsuyoshi Takami
    Hisataka Moriwaki
    Annals of Hematology, 2012, 91 : 705 - 714
  • [2] Serum soluble interleukin-2 receptor (sIL-2R) level is associated with the outcome of patients with diffuse large B cell lymphoma treated with R-CHOP regimens
    Goto, Naoe
    Tsurumi, Hisashi
    Goto, Hideko
    Shimomura, Yoriko Ino
    Kasahara, Senji
    Hara, Takeshi
    Yasuda, Ichiro
    Shimizu, Masahito
    Murakami, Nobuo
    Yoshikawa, Takeshi
    Fukuno, Kenji
    Takahashi, Takeshi
    Kito, Yusuke
    Takami, Tsuyoshi
    Moriwaki, Hisataka
    ANNALS OF HEMATOLOGY, 2012, 91 (05) : 705 - 714
  • [3] Soluble Interleukin-2 Receptors (sIL-2R) Is An Independent Prognostic Factor for Patients with Diffuse Large B Cell Lymphoma Treated with R-CHOP
    Nishimura, Noriko
    Yokoyama, Masahiro
    Takeuchi, Kengo
    Tsuyama, Naoko
    Nara, Eriko
    Suzuki, Kazuhito
    Nakano, Kenji
    Ueda, Kyoko
    Mishima, Yuko
    Sakajiri, Sakura
    Takahashi, Shunji
    Terui, Yasuhito
    Hatake, Kiyohiko
    BLOOD, 2011, 118 (21) : 1150 - 1150
  • [4] Serum soluble Fas level determines clinical outcome of patients with diffuse large B-cell lymphoma treated with CHOP and R-CHOP
    Takeshi Hara
    Hisashi Tsurumi
    Naoe Goto
    Nobuhiro Kanemura
    Takeshi Yoshikawa
    Senji Kasahara
    Toshiki Yamada
    Michio Sawada
    Hideko Goto
    Kenji Fukuno
    Jun-ichi Kitagawa
    Ichiro Yasuda
    Naoki Katsumura
    Masao Takemura
    Takeshi Takahashi
    Tsuyoshi Takami
    Hisataka Moriwaki
    Journal of Cancer Research and Clinical Oncology, 2009, 135 : 1421 - 1428
  • [5] Serum soluble Fas level determines clinical outcome of patients with diffuse large B-cell lymphoma treated with CHOP and R-CHOP
    Hara, Takeshi
    Tsurumi, Hisashi
    Goto, Naoe
    Kanemura, Nobuhiro
    Yoshikawa, Takeshi
    Kasahara, Senji
    Yamada, Toshiki
    Sawada, Michio
    Goto, Hideko
    Fukuno, Kenji
    Kitagawa, Jun-ichi
    Yasuda, Ichiro
    Katsumura, Naoki
    Takemura, Masao
    Takahashi, Takeshi
    Takami, Tsuyoshi
    Moriwaki, Hisataka
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (10) : 1421 - 1428
  • [6] Prognostic impact of serum soluble interleukin-2 receptor level at diagnosis in elderly patients with diffuse large B-cell lymphoma treated with R-CHOP
    Umino, Kento
    Fujiwara, Shin-Ichiro
    Minakata, Daisuke
    Yamamoto, Chihiro
    Meguro, Akiko
    Matsuyama, Tomohiro
    Sato, Kazuya
    Ohmine, Ken
    Izumi, Tohru
    Muroi, Kazuo
    Kanda, Yoshinobu
    LEUKEMIA & LYMPHOMA, 2019, 60 (03) : 734 - 741
  • [7] Prognostic Impact of Gender in Diffuse Large B Cell Lymphoma Patients Treated with R-CHOP Therapy
    Takahashi, Hiroyuki
    Tomita, Naoto
    Ishiyama, Yasufumi
    Koyama, Satoshi
    Miyashita, Kazuho
    Nakajima, Yuki
    Hattori, Yukako
    Motohashi, Kenji
    Takasaki, Hirotaka
    Kawasaki, Rika
    Hagihara, Maki
    Hashimoto, Chizuko
    Takemura, Sachiya
    Fujimaki, Katsumichi
    Taguchi, Jun
    Sakai, Rika
    Fujita, Hiroyuki
    Fujisawa, Shin
    Harano, Hiroshi
    Ishigatsubo, Yoshiaki
    BLOOD, 2014, 124 (21)
  • [8] Prognostic Impact Of Gender In Diffuse Large B Cell Lymphoma Patients Treated With R-CHOP Therapy
    Takahashi, Hiroyuki
    Tomita, Naoto
    Kawasaki, Rika
    Hashimoto, Chizuko
    Yamazaki, Etsuko
    Taguchi, Jun
    Sakai, Rika
    Fujisawa, Shin
    Ogawa, Koji
    Ishigatsubo, Yoshiaki
    BLOOD, 2013, 122 (21)
  • [9] Prognostic significance of primary extranodal diffuse large B-cell lymphoma (DLBCL) in patients treated with R-CHOP
    Hui, D.
    Proctor, B.
    Donaldson, J.
    Shenkier, T.
    Hoskins, P.
    Klasa, R.
    Savage, K.
    Gascoyne, R.
    Connors, J. M.
    Sehn, L. L.
    ANNALS OF ONCOLOGY, 2008, 19 : 186 - 187
  • [10] Prognostic significance of primary extranodal diffuse large B-cell lymphoma (DLBCL) in patients treated with R-CHOP
    Proctor, B. R.
    Hui, D.
    Donaldson, J.
    Savage, K. J.
    Shenkier, T. N.
    Hoskins, P. J.
    Klasa, R.
    Randy, G.
    Joseph, C.
    Sehn, L. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345